Concepedia

Stacey Ruiz

SR

9

Publications

1.8K

Citations

9

H-Index

1992

Active since

Affiliations

Reata Pharmaceuticals (United States)(Current)

Renal Associates P. A.

University of Alabama at Birmingham

Statistics Collaborative

The University of Texas Southwestern Medical Center

Stacey Ruiz is an author at Reata Pharmaceuticals (United States) specializing in medicine, clinical trial evaluation, and clinical trials.

Top concepts

Publications per year

1992–2021

9

Publications

9

Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes

Pablo E. Pérgola, Philip Raskin, Robert D. Toto et al. · New England Journal of Medicine · 2011 · 868 citations · Full text

Fatty Acid Synthase: A Metabolic Enzyme and Candidate Oncogene in Prostate Cancer

Toshiro Migita, Stacey Ruiz, A Fornari et al. · JNCI Journal of the National Cancer Institute · 2009 · 381 citations · Full text

Effect of Bardoxolone Methyl on Kidney Function in Patients with T2D and Stage 3b–4 CKD

Pablo E. Pérgola, Melissa Krauth, Jesse W. Huff et al. · American Journal of Nephrology · 2011 · 230 citations · Full text

, , +20

The proteasome inhibitor NPI-0052 is a more effective inducer of apoptosis than bortezomib in lymphocytes from patients with chronic lymphocytic leukemia

Stacey Ruiz, Yelena V. Krupnik, Michael J. Keating et al. · Molecular Cancer Therapeutics · 2006 · 108 citations

Triterpenoid Dihydro-CDDO-Trifluoroethyl Amide Protects against Maladaptive Cardiac Remodeling and Dysfunction in Mice: A Critical Role of Nrf2

Yifan Xing, Ting Niu, Wenjuan Wang et al. · PLoS ONE · 2012 · 61 citations · Full text

Rows per page

1–5 of 9